Trial intelligence / Profile preview

Paroxetine and Sildenafil Combination for Premature Ejaculation

NCT07057011Not yet recruiting

Sponsor
South Valley University
Start
Jul 2025
Primary completion
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of ASP-001 in premature ejaculation (PE) (3 arms), sponsored by South Valley University. Primary endpoint: Treatment of premature ejaculation at 3 months. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

ASP-001
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT07057011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07057011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call